全文获取类型
收费全文 | 15526篇 |
免费 | 1310篇 |
国内免费 | 475篇 |
专业分类
耳鼻咽喉 | 190篇 |
儿科学 | 335篇 |
妇产科学 | 52篇 |
基础医学 | 1130篇 |
口腔科学 | 2383篇 |
临床医学 | 858篇 |
内科学 | 2409篇 |
皮肤病学 | 156篇 |
神经病学 | 319篇 |
特种医学 | 484篇 |
外国民族医学 | 1篇 |
外科学 | 5410篇 |
综合类 | 1738篇 |
现状与发展 | 2篇 |
预防医学 | 264篇 |
眼科学 | 340篇 |
药学 | 672篇 |
6篇 | |
中国医学 | 405篇 |
肿瘤学 | 157篇 |
出版年
2024年 | 31篇 |
2023年 | 325篇 |
2022年 | 721篇 |
2021年 | 894篇 |
2020年 | 593篇 |
2019年 | 636篇 |
2018年 | 644篇 |
2017年 | 608篇 |
2016年 | 554篇 |
2015年 | 548篇 |
2014年 | 997篇 |
2013年 | 1114篇 |
2012年 | 777篇 |
2011年 | 927篇 |
2010年 | 659篇 |
2009年 | 694篇 |
2008年 | 727篇 |
2007年 | 673篇 |
2006年 | 656篇 |
2005年 | 622篇 |
2004年 | 546篇 |
2003年 | 469篇 |
2002年 | 401篇 |
2001年 | 339篇 |
2000年 | 240篇 |
1999年 | 253篇 |
1998年 | 237篇 |
1997年 | 182篇 |
1996年 | 158篇 |
1995年 | 139篇 |
1994年 | 137篇 |
1993年 | 91篇 |
1992年 | 118篇 |
1991年 | 91篇 |
1990年 | 68篇 |
1989年 | 72篇 |
1988年 | 49篇 |
1987年 | 43篇 |
1986年 | 49篇 |
1985年 | 50篇 |
1984年 | 27篇 |
1983年 | 19篇 |
1982年 | 26篇 |
1981年 | 19篇 |
1980年 | 23篇 |
1979年 | 18篇 |
1978年 | 19篇 |
1977年 | 7篇 |
1976年 | 12篇 |
1975年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 328 毫秒
31.
32.
On the Role of Proteasomes in Cell Biology and Proteasome Inhibition as a Novel Frontier in the Development of Immunosuppressants 总被引:2,自引:0,他引:2
Jiangping Wu 《American journal of transplantation》2002,2(10):904-912
The proteasome, a large protease complex in cells, is the major machinery for protein degradation. It was previously considered a humble garbage collector, performing housekeeping duties to remove misfolded or spent proteins. Until recently, the interests of immunologists in proteasomes were focused largely on its role in antigen processing. Its real importance in cell biology has only been revealed contemporarily due to the availability of relatively specific inhibitors. It has now become increasingly clear that many aspects of immune responses highly depend on proper proteasome activity. Recently, a proteasome inhibitor has been successfully used to prevent acute as well as ongoing heart allograft rejection in mice. Such inhibitors are also efficacious in treating several autoimmune diseases, such as arthritis, psoriasis, and probably type I diabetes, in animal models. Phase II and III clinical trials of proteasome inhibitors in treating various tumors have shown promising results, and the side-effects of these drugs are tolerable. Therefore, proteasome inhibition represents a new and promising frontier in immunosuppressant development. 相似文献
33.
Geoffrey G. Hallock M.D. 《Aesthetic plastic surgery》1989,13(4):285-289
Reconstitution of the nasal scaffolding with maintainence of soft tissue proportions either following severe facial trauma or as a sequela to aesthetic rhinoplasty misadventures frequently is best achieved using the stability afforded by bone grafts. Split cranial bone grafts offer many advantages and may be the donor site of choice, and may even allow such surgery to be performed on an outpatient basis in some cases. The use of miniplate or screw osteosynthesis, now commonly accepted as a superior technique in craniomaxillofacial procedures, may simplify fixation of these calvarial nasal bone grafts with an apparent decrease in the risk of resorption. 相似文献
34.
目的 探讨因鼻小柱过短所致鼻尖低平畸形的矫治方法.方法 对8例鼻尖低平伴鼻小柱过短者,采用鼻小柱切口,首先应用肋软骨或Medpor行支撑杆移植矫正撑起鼻尖,鼻小柱切口的继发创面采用耳垂复合组织游离移植修复.结果 8例游离移植的耳垂复合组织均成活良好,随访1~2年形态满意,色泽与周围组织无明显差别,供区无明显继发畸形.结论 应用耳垂复合组织游离移植修复鼻小柱过短畸形,不仅适用于外伤性缺损修复,而且也适用于鼻部的美容性修复,是一种患者容易接受、操作简单安全、疗效好、供区无后遗明显继发畸形的修复方法. 相似文献
35.
Christopher G. Acker Richard Flick Ron Shapiro Velma P. Scantlebury Mark L. Jordan Carlos Vivas Arthur Greenberg John P. Johnson 《American journal of transplantation》2002,2(1):57-61
Delayed graft function (DGF) in cadaver kidney transplants is a common problem and is often due to acute tubular necrosis (ATN). DGF in transplants may have a deleterious effect on long-term graft survival. Since thyroid hormone has been shown to hasten recovery from ATN in experimental models, we designed a trial to determine if a defined course of triiodothyronine (T3) would improve the short- or long-term outcome of patients with DGF in cadaveric transplants. A prospective, randomized, placebo controlled, double blind trial of T3 was carried out in patients with DGF in cadaveric renal transplants. End-points were percentage requiring dialysis, percentage recovering function, time to recovery and length of hospital stay. Long-term outcomes were percentage grafts functioning at 1 year and mean serum creatinine at 1 year. Forty-four patients were randomized to receive either T3 or placebo. Three patients were dropped from each group when early biopsies disclosed that DGF was due to rejection. The groups were well matched by age, cold ischemia time of the graft, and percentage reactivity to a random panel of antigens. Baseline thyroid function studies, including T3, reverse T3 (rT3), and thyroid stimulating hormone (TSH) levels, were similar between the two groups and typical of 'euthyroid-sick syndrome'. T3 had no effect on percentage requiring dialysis, time to recovery, percentage recovering function, or length of stay. At 1 year follow-up, graft function was similar in both groups and significantly lower than that seen in patients with good initial function. Thyroid hormone, given early in the course of DGF in cadaver kidney recipients, had no effect on the course of DGF. Long-term graft function is impaired in patients who experience post-transplant DGF compared to those who have good initial function. 相似文献
36.
The Broad Spectrum of Quality in Deceased Donor Kidneys 总被引:7,自引:6,他引:1
Jesse D. Schold Bruce Kaplan Rajendra S. Baliga Herwig-Ulf Meier-Kriesche 《American journal of transplantation》2005,5(4):757-765
The quality of the deceased donor organ clearly is one of the most crucial factors in determining graft survival and function in recipients of a kidney transplant. There has been considerable effort made towards evaluating these organs culminating in an amendment to allocation policy with the introduction of the expanded criteria donor (ECD) policy.
Our study, from first solitary adult deceased donor transplant recipients from 1996 to 2002 in the National Scientific Transplant Registry database, presents a donor kidney risk grade based on significant donor characteristics, donor–recipient matches and cold ischemia time, generated directly from their risk for graft loss. We investigated the impact of our donor risk grade in a naïve cohort on short- and long-term graft survival, as well as in subgroups of the population.
The projected half-lives for overall graft survival in recipients by donor risk grade were I (10.7 years), II (10.0 years), III (7.9 years), IV (5.7 years) and V (4.5 years). This study indicates that there is great variability in the quality of deceased donor kidneys and that the assessment of risk might be enhanced by this scoring system as compared to the simple two-tiered system of the current ECD classification. 相似文献
Our study, from first solitary adult deceased donor transplant recipients from 1996 to 2002 in the National Scientific Transplant Registry database, presents a donor kidney risk grade based on significant donor characteristics, donor–recipient matches and cold ischemia time, generated directly from their risk for graft loss. We investigated the impact of our donor risk grade in a naïve cohort on short- and long-term graft survival, as well as in subgroups of the population.
The projected half-lives for overall graft survival in recipients by donor risk grade were I (10.7 years), II (10.0 years), III (7.9 years), IV (5.7 years) and V (4.5 years). This study indicates that there is great variability in the quality of deceased donor kidneys and that the assessment of risk might be enhanced by this scoring system as compared to the simple two-tiered system of the current ECD classification. 相似文献
37.
R. A. Wolfe F. B. LaPorte A. M. Rodgers E. C. Roys G. Fant A. B. Leichtman 《American journal of transplantation》2007,7(S1):1404-1411
Turndowns of offers of deceased donor kidneys for transplantation can contribute to inefficiencies in the organ distribution system and inequality in access to donated organs. Match run data were obtained for 4967 'good' kidneys placed and transplanted in 2005 after fewer than 50 offers. These kidneys were not recovered from donation after cardiac death or expanded criteria donors, or from donors with a history of substance abuse. On average, these good kidneys were not accepted until after seven offers to candidates and after offers to 2.4 programs. Models for the likelihood of acceptance found several donor and candidate characteristics to be significantly related to acceptance rates (p < 0.05). After accounting for these variables, there remained 2- to 3-fold differences among transplant programs in acceptance rates. These models could be used to identify kidney transplant centers with exceptional acceptance practices. Several strategies might be employed to increase acceptance rates for good organs. 相似文献
38.
39.
组织工程化表皮膜片构建及其在供皮区的应用研究 总被引:2,自引:0,他引:2
目的构建组织工程化表皮细胞膜片并应用于供皮区创面治疗。方法利用患者少量自体或同种异体正常皮肤分离、培养、扩增的表皮细胞,接种于壳聚糖明胶膜构建成表皮细胞膜片;将膜片移植于治疗组供皮区创面、适度加压,同时设立对照组:空白材料对照以及传统油纱布对照覆盖创面。于术后5~10d、30d、90d行大体观察、组织学检查、广谱角蛋白、外皮蛋白、层粘连蛋白、免疫组织化学检测以及Ⅰ、Ⅲ型胶原比值测定(偏光显微镜、RTPCR)。结果利用自体及异体表皮细胞和壳聚糖明胶膜能够构建出人表皮细胞膜片,应用于临床供皮区创面治疗15例,经过3个月随访,疗效肯定。移植膜片创面愈合时间(8.1±1.3)d,空白材料对照区为(16.2±3.8)d,空白油纱布对照区为(23.0±5.8)d。移植膜片存活良好,结构较完整、术后30d及90d观察:12例无明显增生,3例有轻度增生(20.0%),而空白油纱布对照区11例遗留增生性瘢痕(74.4%,χ2=8.127,P<0.01)。结论表皮细胞-壳聚糖明胶膜片能促进供皮区创面早期愈合并减少后期瘢痕增生,具有良好治疗效果。 相似文献
40.
目的探讨第2足趾腓侧皮瓣移植的应用解剖及临床应用的适应证、手术方法和优缺点等。方法新鲜成人尸体足左、右各10只,经灌注、解剖、测量,了解皮瓣的血供范围和相关血管、神经的外径。临床应用17例修复手部皮肤缺损,了解皮瓣的成活及功能恢复情况。结果灌注剂可达整个第2足趾及相邻趾蹼,测得第2足趾跖趾关节处腓侧固有动脉、趾背静脉分别为(1.0±0.2)mm、(0.9±0.2)mm;临床应用17例移植皮瓣全部成活,手、足部均无感染。经半年以上随访,被修复手指外观、颜色接近正常,供足无疼痛和植皮破溃现象发生。结论第2足趾腓侧皮瓣血供可靠,口径适于吻合,质地好,适于手指皮肤确实的修复。 相似文献